Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Cancer Cachexia Global Clinical Trials Review, H1

Cancer Cachexia Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Cancer Cachexia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Cancer Cachexia Global Clinical Trials Review, H1, 2015" provides an overview of Cancer Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Cachexia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Cancer Cachexia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Cancer Cachexia to Musculoskeletal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Cancer Cachexia to Musculoskeletal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Cancer Cachexia 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Cancer Cachexia Therapeutics Clinical Trials 31

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Helsinn Healthcare S.A. (Inactive) 33

Clinical Trial Overview of Helsinn Healthcare S.A. (Inactive) 33

Medpace, Inc. 34

Clinical Trial Overview of Medpace, Inc. 34

Helsinn Holding S.A. 35

Clinical Trial Overview of Helsinn Holding S.A. 35

Ono Pharmaceutical Co., Ltd. 36

Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 36

Ohr Pharmaceutical Inc. 37

Clinical Trial Overview of Ohr Pharmaceutical Inc. 37

Novartis AG 38

Clinical Trial Overview of Novartis AG 38

Merck & Co., Inc. 39

Clinical Trial Overview of Merck & Co., Inc. 39

GTx, Inc. 40

Clinical Trial Overview of GTx, Inc. 40

Ark Therapeutics Group Plc 41

Clinical Trial Overview of Ark Therapeutics Group Plc 41

Aeterna Zentaris Inc. 42

Clinical Trial Overview of Aeterna Zentaris Inc. 42

Clinical Trial Overview of Top Institutes / Government 43

National Cancer Institute 43

Clinical Trial Overview of National Cancer Institute 43

North Central Cancer Treatment Group 44

Clinical Trial Overview of North Central Cancer Treatment Group 44

Baylor College of Medicine 45

Clinical Trial Overview of Baylor College of Medicine 45

Cantonal Hospital 46

Clinical Trial Overview of Cantonal Hospital 46

Cedars-Sinai Medical Center 47

Clinical Trial Overview of Cedars-Sinai Medical Center 47

German Cancer Research Center 48

Clinical Trial Overview of German Cancer Research Center 48

H. Lee Moffitt Cancer Center & Research Institute, Inc. 49

Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute, Inc. 49

Isfahan University of Medical Sciences 50

Clinical Trial Overview of Isfahan University of Medical Sciences 50

Maxima Medical Center 51

Clinical Trial Overview of Maxima Medical Center 51

McGill University 52

Clinical Trial Overview of McGill University 52

Five Key Clinical Profiles 53

Appendix 86

Abbreviations 86

Definitions 86

Research Methodology 87

Secondary Research 87

About GlobalData 88

Contact Us 88

Disclaimer 88

Source 89

List of Figures

Cancer Cachexia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Cancer Cachexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cancer Cachexia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Cancer Cachexia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Cancer Cachexia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Cancer Cachexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Cancer Cachexia to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 15

Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cancer Cachexia to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 18

Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cancer Cachexia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Cancer Cachexia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cancer Cachexia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cancer Cachexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Cancer Cachexia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Cancer Cachexia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Cancer Cachexia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Cancer Cachexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 87

List of Tables

Cancer Cachexia Therapeutics, Global, Clinical Trials by Region, 2015* 7

Cancer Cachexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cancer Cachexia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Cancer Cachexia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Cancer Cachexia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Cancer Cachexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Cancer Cachexia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Cancer Cachexia to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 15

Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cancer Cachexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cancer Cachexia to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 18

Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cancer Cachexia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cancer Cachexia Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Cancer Cachexia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Cancer Cachexia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cancer Cachexia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cancer Cachexia Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Cancer Cachexia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Cancer Cachexia Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Cancer Cachexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Cancer Cachexia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Cancer Cachexia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Cancer Cachexia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Cancer Cachexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinn Healthcare S.A. (Inactive), 2015* 33

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medpace, Inc., 2015* 34

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinn Holding S.A., 2015* 35

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2015* 36

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohr Pharmaceutical Inc., 2015* 37

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 38

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 39

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by GTx, Inc., 2015* 40

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ark Therapeutics Group Plc, 2015* 41

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeterna Zentaris Inc., 2015* 42

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 43

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2015* 44

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 45

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cantonal Hospital, 2015* 46

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2015* 47

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by German Cancer Research Center, 2015* 48

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, Inc., 2015* 49

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 50

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maxima Medical Center, 2015* 51

Cancer Cachexia Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University, 2015* 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Medpace, Inc.

Helsinn Holding S.A.

Ono Pharmaceutical Co., Ltd.

Ohr Pharmaceutical Inc.

Novartis AG

Merck & Co., Inc.

GTx, Inc.

Ark Therapeutics Group Plc

Aeterna Zentaris Inc.

Cancer Cachexia Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Cancer Cachexia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com